FDA Cleared Lilly Foundayo in $9.3B Obesity Race
Lilly cleared Foundayo on April 1, but the label carries a required post-market trial for four serious risks, including MACE and liver injury.
Lilly cleared Foundayo on April 1, but the label carries a required post-market trial for four serious risks, including MACE and liver injury.
AstraZeneca's $1.3B CinCor buy paid off: FDA cleared Baxfendy, first-in-class for hypertension, with Leerink's $10B upside scenario on the table.
Regeneron pays $125M upfront in a $2.3B Parabilis collaboration to build antibody-helicon conjugates, a drug class that doesn't exist yet.
A $3.7 billion drug acquisition is unraveling: 20 deaths, a market withdrawal demand, and now FDA allegations of manipulated trial data.
Boston Scientific paid $1.5B for 34% of MiRus and locked in a $3B option for its SIEGEL TAVR system, one year after scrapping its own valve program.
Enhertu's $5.4B annual sales projection grows with dual early breast cancer clearance, but patients who used it before surgery can't get it after.
BioMarin's $270M Inozyme bet just got complicated: BMN 401 hit the biomarker endpoint but missed skeletal healing and all secondary goals.
Adani Green sold $750M in bonds while its founder personally orchestrated bribe payments to Indian officials, the SEC alleged in late 2024.
CFPB just scrapped disparate impact under ECOA, but mortgage lenders and state AGs in New York, New Jersey, and Massachusetts won't play along.
Judge Barrett called Peters a 'charlatan' who'd do it again. Colorado's governor cut her 9-year sentence anyway, after just 18 months.
NYDFS is telling NY lenders that disparate impact still applies, directly contradicting Trump's EO 14281 and the CFPB's Regulation B rewrite.
Jules v. Balazs locks federal courts onto post-arbitration jurisdiction for stayed FAA cases, closing the Badgerow gap businesses feared.
Three malicious node-ipc versions drain cloud keys, SSH creds, and CI/CD tokens via DNS; attacker hijacked an inactive npm maintainer's account.
Three AI coding agents fell at Pwn2Own Berlin for $65K in prizes, and the patch window for Cursor and Codex won't close for 90 days.
FDIC's transaction-level data shows the $49M-threshold depositors who drained SVB in six days, and they ran at Signature and First Republic too.